Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Letter to Editor "Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs": Important concerns on the validity of this article.
Barrière J, Frank F, Besancon L, Samuel A, Saada V, Billy E, Al-Ahmad A, Florens N, Seitz-Polski B, Robert J. Barrière J, et al. Among authors: saada v. Food Chem Toxicol. 2023 Aug;178:113897. doi: 10.1016/j.fct.2023.113897. Epub 2023 Jun 14. Food Chem Toxicol. 2023. PMID: 37328089 Free PMC article. No abstract available.
When monoclonal gammopathy-associated chronic neutrophilic leukemia is a reactive process distinct from a clonal myeloproliferative neoplasm: Lessons from mistakes.
Willekens C, Chahine C, Dragani M, Khalife-Hachem S, Bigenwald C, Rossignol J, Castilla-Llorente C, Danu A, Michot JM, Saada V, Cotteret S, Marzac C, Renneville A, Plo I, Broutin S, Bosselut N, Cassinat B, Lazarovici J, Droin N, De Botton S. Willekens C, et al. Among authors: saada v. EJHaem. 2023 May 19;4(3):823-826. doi: 10.1002/jha2.713. eCollection 2023 Aug. EJHaem. 2023. PMID: 37601857 Free PMC article. No abstract available.
The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection.
Lécuyer D, Nardacci R, Tannous D, Gutierrez-Mateyron E, Deva Nathan A, Subra F, Di Primio C, Quaranta P, Petit V, Richetta C, Mostefa-Kara A, Del Nonno F, Falasca L, Marlin R, Maisonnasse P, Delahousse J, Pascaud J, Deprez E, Naigeon M, Chaput N, Paci A, Saada V, Ghez D, Mariette X, Costa M, Pistello M, Allouch A, Delelis O, Piacentini M, Le Grand R, Perfettini JL. Lécuyer D, et al. Among authors: saada v. Front Immunol. 2023 Oct 18;14:1270081. doi: 10.3389/fimmu.2023.1270081. eCollection 2023. Front Immunol. 2023. PMID: 37920468 Free PMC article.
Women and health professionals' perspectives on a conditional cash transfer programme to improve pregnancy follow-up: a qualitative analysis of the NAITRE randomised controlled study.
Bardou M, Meunier-Beillard N, Godard-Marceau A, Deruelle P, Virtos C, Eckman-Lacroix A, Debras E, Schmitz T; NAITRE Study group. Bardou M, et al. BMJ Open. 2023 Mar 29;13(3):e067066. doi: 10.1136/bmjopen-2022-067066. BMJ Open. 2023. PMID: 36990483 Free PMC article. Clinical Trial.
[The fight against scientific fraud: A thankless but necessary task].
Barrière J, Frank F, Besancon L, Samuel A, Saada V, Billy E, Seitz-Polski B, Robert J. Barrière J, et al. Among authors: saada v. Bull Cancer. 2022 Oct;109(10):996-998. doi: 10.1016/j.bulcan.2022.06.013. Epub 2022 Aug 31. Bull Cancer. 2022. PMID: 36055805 French. No abstract available.
70 results